Indeed, NKG2D-CAR-NK cells are shown to perform enhanced in vivo cytotoxicity against hepatocellular carcinoma cells in a SNU449 (HCC cell line) xenograft model [141]. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.